B2M and liver cancer: The tumor-specific marker genes (i.e. EPCAM, KRT8, EPCAM, B2M, FCA1 and KRT19) were also highly expressed in the tumor regions of prostate, colorectal, liver cancer, pancreas and breast cancer.